We provide the
information that counts.
Our rapid, on-farm diagnostics provide livestock producers with information they need to make informed management and treatment decisions. Through accurate, onsite disease prediction and detection, producers can provide more precise animal care and meet the growing global demand for quality protein.
News that counts.
Congratulations to sister company Ad Astra Diagnostics on FDA clearance of the QScout™ system for human hematology testing!
​
Ad Astra Diagnostics (AAD), developer of rapid diagnostic systems, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its QScout™ rapid-result hematology system, which provides fast, point-of-care white blood cell counts (WBCs), neutrophil-to-lymphocyte ratio, and differentiates the number and percent of five types of mature WBCs as well as immature granulocytes - see full press release
Together, we can make a difference.
Our team is passionate about providing livestock producers with actionable information that makes them more profitable while minimizing antibiotic use. Simply put, we’re committed to your future – and the future of agriculture.
Increase production and quality.
Make better animal health decisions.
Ensure more precise use of antibiotics.
QScout® BLD helps beef producers decide when to use antibiotics, preventing losses and maximizing profits.
Early detection pays.
With powerful diagnostic technology, we can detect diseases earlier so producers can take action earlier – and prevent losses. In the dairy industry, our QScout® MLD test detects subclinical mastitis infections before losses occur.